IDXX

2026Q2BMO

IDEXX Laboratories Inc primary · HEALTHCARE · DIAGNOSTICS & RESEARCH

Report 2026-08-04 · Fiscal end 2026-06-30 · Features as of 2026-08-03

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS3.95
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move2.9%
IV front—
P/C full—
P/C front—
Features as of2026-08-03

Run-up

Close—
Ret 5d+2.1%
Ret 10d+0.7%
Ret 20d+0.5%
Ret 30d+1.0%

Post-Earnings Data

Results & reaction

Print

Actual EPS
4.27Beat
Estimated EPS3.95
Actual revenue
1.2B
Surprise %+8.1%
Beat / missBeat
Beat streak 44
Beat streak 88

Reaction

1-day stock reaction-2.4%
Implied vs actual

Implied 2.9%Actual 6.1%

Gap reaction+6.1%
Day result+3.6%
Next-day upNo
Realized / IV2.10×

Post tape

Post 5d-0.2%
Post 10d-5.9%
Post volume1.6M
Vol ×10d2.80×
Vol ×20d2.56×
Post range6.6%